Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126512201 | 12651220 | 1 | I | 2013 | 20160610 | 20160815 | 20160815 | EXP | US-PFIZER INC-2016297708 | PFIZER | 56.00 | YR | F | Y | 83.91000 | KG | 20160815 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126512201 | 12651220 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 225 MG, CAPSULE ONCE A DAY IN THE MORNING | Y | J11524 | 20699 | 225 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||
| 126512201 | 12651220 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 37.5 MG, 1X/DAY | Y | 20699 | 37.5 | MG | PROLONGED-RELEASE CAPSULE | QD | |||||
| 126512201 | 12651220 | 3 | C | IMITREX | SUMATRIPTAN SUCCINATE | 1 | Oral | 100 MG, AS NEEDED (1 TABLET AS NEEDED) | 0 | 100 | MG | TABLET | |||||||
| 126512201 | 12651220 | 4 | C | OXCARBAZEPINE. | OXCARBAZEPINE | 1 | Oral | 150 MG, 2X/DAY | 0 | 150 | MG | TABLET | BID | ||||||
| 126512201 | 12651220 | 5 | C | FELODIPINE. | FELODIPINE | 1 | Oral | 5 MG, 1X/DAY | 0 | 5 | MG | TABLET | QD | ||||||
| 126512201 | 12651220 | 6 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | ||||||
| 126512201 | 12651220 | 7 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 | TABLET | |||||||||||
| 126512201 | 12651220 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 75 MCG TABLET ONCE A DAY | 0 | 75 | UG | TABLET | QD | ||||||
| 126512201 | 12651220 | 9 | C | LIOTHYRONINE SODIUM. | LIOTHYRONINE SODIUM | 1 | Oral | 5 MCG TABLET TWICE A DAY | 0 | 5 | UG | TABLET | BID | ||||||
| 126512201 | 12651220 | 10 | C | VALIUM | DIAZEPAM | 1 | Oral | 5 MG TABLET PRN | 0 | 5 | MG | TABLET | |||||||
| 126512201 | 12651220 | 11 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | Rectal | 25 MG SUPPOSITORY PRN PER RECTUM | 0 | 25 | MG | SUPPOSITORY | |||||||
| 126512201 | 12651220 | 12 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | 25 MG 2 CAPSULES AS NEEDED | 0 | 50 | MG | CAPSULE | |||||||
| 126512201 | 12651220 | 13 | C | KETAMINE | KETAMINE | 1 | 50 MG/ML NASAL SPRAY PRN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126512201 | 12651220 | 1 | Depression |
| 126512201 | 12651220 | 2 | Post-traumatic stress disorder |
| 126512201 | 12651220 | 3 | Nervous system disorder |
| 126512201 | 12651220 | 4 | Nervous system disorder |
| 126512201 | 12651220 | 5 | Hypertension |
| 126512201 | 12651220 | 6 | Asthma |
| 126512201 | 12651220 | 7 | Hypersensitivity |
| 126512201 | 12651220 | 8 | Hypothyroidism |
| 126512201 | 12651220 | 9 | Hypothyroidism |
| 126512201 | 12651220 | 10 | Muscle spasms |
| 126512201 | 12651220 | 11 | Neurological symptom |
| 126512201 | 12651220 | 12 | Neurological symptom |
| 126512201 | 12651220 | 13 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126512201 | 12651220 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126512201 | 12651220 | Agitation | |
| 126512201 | 12651220 | Anger | |
| 126512201 | 12651220 | Blood pressure fluctuation | |
| 126512201 | 12651220 | Body temperature fluctuation | |
| 126512201 | 12651220 | Cold sweat | |
| 126512201 | 12651220 | Coordination abnormal | |
| 126512201 | 12651220 | Crying | |
| 126512201 | 12651220 | Diarrhoea | |
| 126512201 | 12651220 | Drug withdrawal syndrome | |
| 126512201 | 12651220 | Dysstasia | |
| 126512201 | 12651220 | Eye pain | |
| 126512201 | 12651220 | Gait disturbance | |
| 126512201 | 12651220 | Intentional product misuse | |
| 126512201 | 12651220 | Migraine | |
| 126512201 | 12651220 | Movement disorder | |
| 126512201 | 12651220 | Muscle spasms | |
| 126512201 | 12651220 | Nausea | |
| 126512201 | 12651220 | Nerve injury | |
| 126512201 | 12651220 | Neuralgia | |
| 126512201 | 12651220 | Neuropathy peripheral | |
| 126512201 | 12651220 | Serotonin syndrome | |
| 126512201 | 12651220 | Tremor | |
| 126512201 | 12651220 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126512201 | 12651220 | 1 | 201606 | 0 | ||
| 126512201 | 12651220 | 2 | 20160620 | 0 | ||
| 126512201 | 12651220 | 3 | 201501 | 20160322 | 0 | |
| 126512201 | 12651220 | 4 | 201504 | 0 | ||
| 126512201 | 12651220 | 5 | 2006 | 0 | ||
| 126512201 | 12651220 | 6 | 2014 | 0 | ||
| 126512201 | 12651220 | 8 | 2008 | 0 | ||
| 126512201 | 12651220 | 9 | 2012 | 0 | ||
| 126512201 | 12651220 | 10 | 20160206 | 0 | ||
| 126512201 | 12651220 | 11 | 20160309 | 0 | ||
| 126512201 | 12651220 | 12 | 20160309 | 0 | ||
| 126512201 | 12651220 | 13 | 20160227 | 0 |